| Carl C Capelouto, MD | |
|
470 Northside Cherokee Blvd Ste 201, Canton, GA 30115-8029 | |
| (770) 720-7246 | |
| (770) 720-4620 |
| Full Name | Carl C Capelouto |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 35 Years |
| Location | 470 Northside Cherokee Blvd Ste 201, Canton, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538277710 | NPI | - | NPPES |
| 340011822 | Other | GA | RAILROAD MEDICARE |
| 000708716E | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 039541 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital Cherokee | Canton, GA | Hospital |
| Northside Hospital | Atlanta, GA | Hospital |
| Northside Hospital Forsyth | Cumming, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tift Regional Health System Inc | 2062745169 | 298 |
| Georgia Urology, Pa | 8921094376 | 71 |
| Urological Professional Services, Llc | 9638391717 | 56 |
News Archive
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
A team of experts in disability employment summarized advances in outcomes being achieved in individuals recovering from spinal cord injury.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.
EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that Canaan Partners and Radius Ventures co-led a $30 Million Series F financing designed to support the company through profitability.
› Verified 5 days ago
| Entity Name | Georgia Urology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245250646 PECOS PAC ID: 8921094376 Enrollment ID: O20040422000123 |
News Archive
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
A team of experts in disability employment summarized advances in outcomes being achieved in individuals recovering from spinal cord injury.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.
EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that Canaan Partners and Radius Ventures co-led a $30 Million Series F financing designed to support the company through profitability.
› Verified 5 days ago
| Entity Name | Urological Professional Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033521810 PECOS PAC ID: 9638391717 Enrollment ID: O20141104002579 |
News Archive
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
A team of experts in disability employment summarized advances in outcomes being achieved in individuals recovering from spinal cord injury.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.
EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that Canaan Partners and Radius Ventures co-led a $30 Million Series F financing designed to support the company through profitability.
› Verified 5 days ago
| Entity Name | Tift Regional Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881203305 PECOS PAC ID: 2062745169 Enrollment ID: O20200217002409 |
News Archive
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
A team of experts in disability employment summarized advances in outcomes being achieved in individuals recovering from spinal cord injury.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.
EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that Canaan Partners and Radius Ventures co-led a $30 Million Series F financing designed to support the company through profitability.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carl C Capelouto, MD 1930 Brannan Rd, Mcdonough, GA 30253-4310 Ph: (678) 284-4040 | Carl C Capelouto, MD 470 Northside Cherokee Blvd Ste 201, Canton, GA 30115-8029 Ph: (770) 720-7246 |
News Archive
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
A team of experts in disability employment summarized advances in outcomes being achieved in individuals recovering from spinal cord injury.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies developing therapies to treat hematologic malignancies.
EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that Canaan Partners and Radius Ventures co-led a $30 Million Series F financing designed to support the company through profitability.
› Verified 5 days ago
Mr. Vincent Daniel Dicarlo, MD Urology Medicare: May Accept Medicare Assignments Practice Location: 470 Northside Cherokee Blvd Ste 201, Canton, GA 30115 Phone: 770-720-7246 Fax: 770-720-4620 | |
Wesley Warren Ludwig, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 145 Riverstone Ter Ste 101, Canton, GA 30114 Phone: 770-720-7246 | |
Andrew Kenneth Ostrowski, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2205 Riverstone Blvd Ste 101, Canton, GA 30114 Phone: 678-344-8900 |